N. Di Muzio
Vita-Salute San Raffaele University
CancerInternal medicineRadiologyUrologySurgeryOncologyMedical physicsChemotherapyTomotherapyConcomitantProstatectomyLymphProstate cancerWhole-PelvisToxicityNuclear medicineIn patientAdjuvant radiotherapyPost prostatectomySalvage radiationRadiation therapyColorectal cancerMedicine
236Publications
12H-index
345Citations
Publications 234
Newest
#1N. FossatiH-Index: 4
#2J.R. KarnesH-Index: 3
Last. E. MazzoneH-Index: 1
view all 22 authors...
Source
#1N. FossatiH-Index: 4
Last. G. GandagliaH-Index: 3
view all 25 authors...
Source
#1Elio MazzoneH-Index: 11
#2N. FossatiH-Index: 4
Last. G. GandagliaH-Index: 3
view all 23 authors...
Source
#1N. FossatiH-Index: 4
#2Elio MazzoneH-Index: 11
Last. B. Noris ChiordaH-Index: 1
view all 24 authors...
Source
#1Elio MazzoneH-Index: 11
#2N. FossatiH-Index: 4
Last. B. Noris ChiordaH-Index: 1
view all 23 authors...
Source
#1Cesare CozzariniH-Index: 43
#2Alessandro MagliH-Index: 12
Last. Barbara AvuzziH-Index: 11
view all 22 authors...
Source
#1N. FossatiH-Index: 4
#2Elio MazzoneH-Index: 11
Last. B. Noris ChiordaH-Index: 1
view all 25 authors...
Source
#1Andrei FodorH-Index: 13
#2Chiara Brombin (UniSR: Vita-Salute San Raffaele University)H-Index: 15
Last. N. Di Muzio (UniSR: Vita-Salute San Raffaele University)H-Index: 12
view all 27 authors...
Abstract Aim We report molecular subtype impact on 1325 early breast cancer (BCa) patients treated with whole breast hypofractionated (WBH) adjuvant forward-planned intensity modulated radiotherapy (F-IMRT) without boost. Methods and materials From 02/2009-05/2017 1325 patients with pTis-pT3, pNx-N1aM0 BCa who underwent breast conservation surgery were treated with WBHF-IMRT in our institute, to a total dose of 40 Gy/15 fractions, without boost. Median age: 62 (interquartile range-IQR-:51.14–70....
Source
#1M. MoriH-Index: 5
#2Paolo PassoniH-Index: 22
Last. C. FiorinoH-Index: 7
view all 14 authors...
Source
#2Andrei FodorH-Index: 13
Last. N. Di MuzioH-Index: 12
view all 11 authors...
Source